Ozempic News in 2026: Recalls, Shortages, Studies, and FDA Updates

    Ozempic News in 2026: Recalls, Shortages, Studies, and FDA Updates

    The latest Ozempic news for October 2026: the Ozempic pill, price cuts, Medicare changes, generics in Canada, FDA warnings, lawsuits and heart research.

    Updated October 22, 2026. 2026 has been the busiest year for Ozempic since it launched. The pill version arrived, self-pay prices dropped, Medicare started a weight-loss program, Canada approved the first generics, and new research suggested semaglutide protects the heart in ways that go beyond weight loss. Below is what's new this fall, followed by a timeline of the year and what each change means for people taking Ozempic.

    Latest: September–October 2026

    1. 1Heart benefit goes beyond weight loss (September 24). A new analysis of the SELECT trial, published in the European Heart Journal, found that changes in weight, waist size, blood pressure and blood tests explained at most about half of semaglutide's roughly 20% reduction in heart attacks and strokes. The authors suggest it should be considered a cardiovascular drug in its own right.
    2. 2FDA targets imported "generic Ozempic" sold online (September 23–24). FDA sent warning letters to online sellers marketing unapproved semaglutide injections made for other countries' markets to U.S. buyers without a prescription. No generic semaglutide is approved in the U.S.
    3. 3Lawsuits keep growing (October). The federal gastroparesis litigation (MDL 3094) has passed 4,000 cases, and a separate MDL for NAION vision-loss claims has nearly 250 active cases. No trials or settlements have happened yet. See our Ozempic lawsuit guide.
    4. 4Medicare open enrollment (from October 15). People on Ozempic for diabetes should compare Part D plans now; the 2026 out-of-pocket cap is $2,100, and Medicare's negotiated semaglutide price takes effect January 1, 2027.

    2026 Timeline: Everything That Changed

    Key Ozempic and semaglutide events in 2026

    Date
    What happened
    What it means for you

    January

    FDA asks to remove the suicidal-thoughts warning from weight-loss GLP-1 labels after a review of 91 trials

    No increased risk found; still report mood changes to your doctor

    February

    FDA approves Ozempic tablets; Novo announces a list-price cut to $675, effective January 2027

    A pill option for type 2 diabetes; lower costs for coinsurance plans next year

    March

    FDA sends Novo Nordisk a warning letter over side-effect reporting; Wegovy HD (7.2 mg) approved

    Regulatory scrutiny of safety reporting; a higher-dose option for weight loss

    April

    Foundayo (orforglipron) approved; Canada approves its first generic semaglutide

    A new weight-loss pill without food rules; generics advance outside the U.S.

    May

    Ozempic tablets launch in U.S. pharmacies, replacing Rybelsus

    Daily pill from $149 self-pay

    June

    FDA sends 25 warning letters about misleading compounded GLP-1 marketing; Canada approves a generic Wegovy

    Tighter crackdown on "same as Ozempic" claims

    July

    Medicare GLP-1 Bridge starts: $50/month for eligible members using Wegovy, Zepbound or Foundayo for weight

    Ozempic itself isn't included; it stays covered for diabetes under Part D

    September

    SELECT analysis shows heart benefit beyond weight loss; FDA warns online sellers of imported semaglutide

    Stronger case for semaglutide in heart disease; avoid online "generics"

    Prices: Where Things Stand

    Novo Nordisk sells Ozempic directly at $349 a month for doses up to 1 mg and $499 for 2 mg, with a $199 price for a new patient's first two fills through December 31, 2026. Ozempic tablets start at $149. On January 1, 2027, the list price falls to $675, which mainly helps people whose costs are tied to list price. See our Ozempic cost guide.

    Supply and Generics

    The semaglutide shortage is over; FDA removed it from the shortage list in 2025, which is why legal compounding is now much narrower. In the U.S., generic semaglutide isn't expected before the end of 2031 because of Novo Nordisk's patents. Canada approved several generics in 2026, and FDA has been warning U.S. buyers away from imported versions sold online. See Ozempic vs semaglutide and our compounded semaglutide guide.

    Safety Updates

    European and UK regulators now list NAION, a sudden vision loss in one eye, as a very rare side effect of semaglutide, affecting up to about 1 in 10,000 people. FDA removed suicidal-thought warnings from weight-loss GLP-1 labels after finding no increased risk. The label also notes a risk of food in the stomach during anesthesia, so tell your surgical team you take Ozempic. Our Is Ozempic Safe? guide covers the full picture.

    What to Watch Next

    1. 1January 1, 2027: Ozempic list price drops to $675 and Medicare's negotiated price takes effect.
    2. 2End of 2026: Novo says self-pay prices will be updated after December 31.
    3. 3Early 2027: Lilly plans to file retatrutide with FDA; it remains unapproved until then.
    4. 4Ongoing: summary judgment and discovery in the federal Ozempic lawsuits; no trial date yet.

    For the dated history behind these developments, see the Ozempic timeline from 2017 to the pill.

    For a closer look at what semaglutide trials found for blood pressure, LDL and triglycerides, see Ozempic, blood pressure and cholesterol.

    FAQ

    No. FDA removed semaglutide from its shortage list in 2025, and supply has been stable since.

    Not in the U.S. Generic semaglutide isn't expected before the end of 2031. Canada approved generics in 2026, but they aren't approved for U.S. sale.

    There's no general recall of Ozempic. FDA has warned about counterfeit pens and unapproved imported semaglutide, so buy only from licensed U.S. pharmacies.

    Yes. Ozempic tablets for type 2 diabetes launched in the U.S. in May 2026, replacing Rybelsus.

    Yes for self-pay buyers: $349 a month for most doses, and tablets from $149. The list price drops to $675 on January 1, 2027.

    Sources

    Dr. Sheri Tomas

    Author

    Published August 12, 2026
    Share:TwitterFacebook

    Comments (0)

    Be the first to comment on this article.

    More articles

    How Does Ozempic Work?